Kenneth Piller, Ph.D.

CBES Area of Interest:

As co-founder of SoyMeds, Inc., we use a soy-based platform for production of protein-based therapeutics that can be used to prevent, diagnose and treat disease. We have expressed vaccine antigens (subunit antigens, VLPs, etc), myelin proteins involved with multiple sclerosis, and the only non-cadaver source of human thyroglobulin that could set a new industry standard as a diagnostic. Soy-derived proteins address many hurdles associated with vaccination and existing therapies (or lack of), including cost, cold chain, long term storage, manufacture and purification, and in addition posses the ability to generate recombinant proteins that are recalcitrant to expression in existing systems.

CBES Area of Expertise:

Biotechnology; Protein-based therapeutics, Vaccines and Toleragens, Diagnostic proteins, Transgenic soybeans, Seed-based protein expression platform.